Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT demonstrates a positive outlook due to notable improvements in both occupancy and rent coverage, indicating a strengthening operational performance in the healthcare real estate sector. The anticipated recovery within the seniors housing managed portfolio is expected to enhance the company's leverage profile, positioning Sabra for accretive growth opportunities. Furthermore, an upward adjustment in the Funds From Operations (FFO) estimates for 2025, now projected at $1.54 per share, reflects financial momentum primarily driven by strategic equity issuance and favorable investment conditions.

Bears say

Sabra Health Care REIT faces a challenging operating environment, as many individual operators struggle to meet rent obligations amid rising inflationary costs. The company is trading near the upper end of its 10-year stock valuation range, suggesting a lack of upside potential given its current cost of equity, which may hinder immediate earnings growth from potential acquisitions. Additionally, with leverage not as low compared to several peers, Sabra's financial position appears less advantageous, further impacting its overall outlook.

SBRA has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 8 analysts, SBRA has a Hold consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.